Dr. Yuliya Afinogenova, MD

Dr. Afinogenova practices at Atlantic Medical Group in Morristown, New Jersey.

Dr. Afinogenova's NPI, 1932588498, was assigned on May 29, 2015. Dr. Afinogenova graduated from Harvard Medical School in 2015. Dr. Afinogenova holds New Jersey license 25MA11451300.

Dr. Afinogenova's primary practice is Atlantic Medical Group, at 435 South St Ste 340 Suite 340, Morristown, NJ 07960. The practice phone is (973) 971-4599.

Dr. Afinogenova's primary practice is Atlantic Medical Group in Morristown, New Jersey. Dr. Afinogenova is also affiliated with Morristown Medical Center. The medical group on file is Atlantic Medical Group. Dmand AI also links Dr. Afinogenova to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Afinogenova practices, 7 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Afinogenova's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Afinogenova is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Afinogenova's licenses on file in 2 states: New Jersey and Connecticut.

Dmand AI lists arthritis, joint arthropathy, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Dr. Afinogenova treats.

CMS data shows 465 Medicare services from Dr. Afinogenova across 6 procedure codes in 2024, for 145 Medicare patients. Medicare paid $37,243 for them. Every service was in an office.

CMS counts 145 Medicare patients who saw Dr. Afinogenova in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Afinogenova's median patient age at 58, with 76% women.

In 2024, Dr. Afinogenova wrote 297 Medicare Part D claims for 92 patients. 86% of them were for generic drugs. CMS names the drug for 160 of them, across 7 drugs with 11 or more claims each, at $1,501 in total drug cost. In 2023, CMS named 212 claims across 8 drugs.

Dr. Afinogenova accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Afinogenova as offering telehealth.

Dmand AI links 10 papers to Dr. Afinogenova, published from 2012 to 2021. The most frequent topics are Allergens, Arachis and Desensitization, Immunologic. Dr. Afinogenova has published most often in J Allergy Clin Immunol Pract. Dr. Afinogenova's most frequent co-authors are Abhijeet Shrikrishna Danve, MD, Jeffrey M. Factor, MD and Gary K. Soffer, MD.

CMS Open Payments shows 122 general payments to Dr. Afinogenova from 27 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 93% of the total. Janssen Pharmaceuticals, Inc paid the most, $448.

Dr. Afinogenova graduated from Harvard Medical School in 2015.

Dr. Afinogenova is in network with 12 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.